Heerlen, NL, 16 Mar 2021 08:00 CET
Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, today announces the repurchase of 800,000 ordinary shares starting 3 May 2021 to cover commitments for the final stock dividend 2020, equivalent to approximately €113 million based on the closing price of the DSM ordinary share on Euronext Amsterdam on 15 March 2021.
The share buyback will be executed within the limitations of the authority granted to the Managing Board by the Annual General Meeting (AGM). The total number of ordinary shares to be repurchased under this program represents approximately 0.4% of ordinary shares issued.
DSM has signed a Discretionary Management Agreement with a bank to commence the execution of the share repurchase program on its behalf and to make trading decisions under the Agreement independently of DSM.
In accordance with regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases. The share repurchase program is anticipated to be completed in Q2 2021.
Senior Director External Communications
+31 45 578 2420
Vice-President Investor Relations
+31 45 578 2864